The European Commission has requested the Scientific committee* to provide guidelines on the benefit risk-assessment of certain phthalates present in the medical devices that:
• are invasive and come into direct contact with the human body,
• (re)administer medicines, body liquids or other substances, including gases, to/from . . .
Oh! It looks like you do not have access to this page.
Find the membership plan that suits you, and within a few minutes you are good to go.
Are you a member already? Log in here.